Fingerprint Changes and Verification Failure Among Patients With Hand Dermatitis

Lee, Chew Kek; Chang, Choong Chor; Johar, Asmah; Puwira, Othman; Roshidah, Baba

doi:10.1001/jamadermatol.2013.1425

Cited by 17 publications

(22 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…ADG is also a feature of several complex ectodermal dysplasias . In addition, acquired ADG has been reported in chronic dermatitis . Whether the skin‐specific isoform of SMARCAD1 plays any role in the pathogenesis of these disorders remains to be explored.…”

Section: Resultsmentioning

confidence: 99%

Mutations inSMARCAD1cause autosomal dominant adermatoglyphia and perturb the expression of epidermal differentiation-associated genes

et al. 2014

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Mutations inSMARCAD1cause autosomal dominant adermatoglyphia and perturb the expression of epidermal differentiation-associated genes

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Although not life‐threatening, fingerprint loss can have legal implications. Fingerprints are individual markers of personal identification and are used extensively in many areas, such as criminology, security, anthropology, travel and immigration, banking transactions, department of motor vehicles, obtaining government documents, confirming membership to use different recreational, government and private facilities, and gaining access to personal computers or cell phones …”

Section: Discussionmentioning

confidence: 99%

“…Fingerprints have long been recognized as an easily accessible means of personal identification. Each individual has unique fingerprints, created from epidermal papillary ridges of the skin during embryonic development, which remain unchanged over time …”

Section: What Is Known and Objectivementioning

confidence: 99%

“…Fingerprints can fade or become damaged in some situations, such as dermatitis, leprosy, electric and radiation injuries, and use of topical corticosteroids for treatment of eczema . In recent years, there have been studies indicating that fingerprints could be altered or lost with the use of some chemotherapeutic agents, including capecitabine and paclitaxel …”

Section: What Is Known and Objectivementioning

confidence: 99%

See 1 more Smart Citation

Capecitabine induced fingerprint changes

et al. 2019

View full text Add to dashboard Cite

What is known and objective Fingerprinting is recognized as an easily accessible means of personal identification; however, fingerprints can be damaged after administration of some chemotherapy agents that result in hand and foot syndrome (HFS). Fingerprint loss may also be due to reasons unrelated to HFS. This study evaluated the incidence of fingerprint changes in patients treated with capecitabine‐containing chemotherapy regimens and its relations to various grades of HFS. Methods Seventy‐one patients who received chemotherapy with or without capecitabine as part of their regimen were enrolled in the study. Fingerprints were collected once before the initiation of chemotherapy and once after the third course of chemotherapy. The fingerprints were examined by the Iranian Society of Forensic Physicians, for probable changes in the post‐chemotherapy states. Results and discussion Thirty‐seven patients were enrolled in the capecitabine group and 34 in a comparison group. Fingerprint changes were observed in 25 (67.6%) of the 37 patients in the capecitabine group and none in the comparison group. There was no correlation between the occurrence or severity of HFS and fingerprint changes (P = 0.880). In capecitabine group, the total dose and course numbers of capecitabine were not significant in patients with and without fingerprint changes. What is new and conclusion Based on our findings, we recommend notifying patients who are considered for capecitabine therapy about the risk of fingerprint changes before the initiation of treatment, as this may have legal implications.

show abstract

“…Cela correspond au vécu des patients, puisque 32 % ont eu des problèmes d'immigration vs 3 % des contrôles, et 40 % ont eu des dif cultés d'identi cation bancaire vs 7 %. La fréquence de l'eczéma des mains et l'utilisation croissante des systèmes d'identi cation des dermatoglyphes dans les entreprises en fait un sujet d'avenir [28].…”

Section: Effets Collatéraux De L'eczémaunclassified

Quoi de neuf en dermatologie clinique ?

Janier

2013

Annales de Dermatologie et de Vénéréologie

View full text Add to dashboard Cite

2013 has been the year of large genetic studies of the GWAS type (Genome wide association studies) in common diseases such as psoriasis and atopic dermatitis, aimed at localization of candidate genes. It was also the year of population-based studies from huge public or private registers. Thus, epidemiologic correlations have been put forward: psoriasis and vascular risk, psoriasis and rhinosinusitis, rosacea and migraine, acne and food habits, eczema and basal-cell carcinoma, vitiligo and lower risk of skin cancer, cutaneous Ro/SS-A pos lupus and cancer, chronic eczema and calcium-channel inhlbitors, pemphigoid and loop diuretics. Risk of IBD induced by isotretinoin has not been confirmed but risk of skin cancer under azathioprine is real. New drug reactions have appeared (pigmentation due to interferon, hypodermitis and sarcoidosis to anti-BRAF, vandetanib) and old ones are revisited (patch-testing of Severe Cutaneous adverse cutaneous reactions, pigmentation due to anti-malarial drugs, neutrophilic dermatosis due to azathioprine). Diane35(®) has been transiently withdrawn in January 2013 but tetrazepam has been withdrawn definitively in July 2013. Original aspects of cutaneous infections will be discussed along with new data on STDs (meningococcemia in MSMs, HPV, Herpes, congenital syphilis). Finally, some important papers about dermoscopy, confocal microscopy and aesthetic dermatology will be presented.

show abstract

Fingerprint Changes and Verification Failure Among Patients With Hand Dermatitis

Abstract: Malaysian National Medical Research Register Identifier: NMRR-11-30-8226

Cited by 17 publications

References 12 publications

Mutations inSMARCAD1cause autosomal dominant adermatoglyphia and perturb the expression of epidermal differentiation-associated genes

Mutations inSMARCAD1cause autosomal dominant adermatoglyphia and perturb the expression of epidermal differentiation-associated genes

Capecitabine induced fingerprint changes

Quoi de neuf en dermatologie clinique ?

Contact Info

Product

Resources

About